Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04JSI
|
|||
| Drug Name |
CAR-T cells targeting CD133
|
|||
| Drug Type |
CAR T Cell Therapy
|
|||
| Indication | Acute myeloid leukaemia [ICD-11: 2A60] | Preclinical | [1] | |
| Company |
Zhujiang Hospital
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Prominin-1 (PROM1) | Target Info | CAR-T-Cell-Therapy | [1] |
| KEGG Pathway | Transcriptional misregulation in cancer | |||
| WikiPathways | Extracellular vesicle-mediated signaling in recipient cells | |||
| Hair Follicle Development: Cytodifferentiation (Part 3 of 3) | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03473457) CAR-T Cells Therapy in Relapsed/Refractory Acute Myeloid Leukemia | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.